eNOS endothelial nitric oxide synthase
ESRD end-stage renal disease




FFQ food frequency questionnaire




g gram




h hour
HDL high-density lipoprotein
Hg mercury
HHS U.S. Department of Health and Human Services
HR hazard ratio
IHD ischemic heart disease




IOM Institute of Medicine
IS ischemic stroke




K potassium
kg kilogram
KHANES Korean Health and Nutrition Examination Survey




L liter
LDL low-density lipoprotein
LOAEL lowest observed adverse effect level
LVEF left ventricular ejection fraction




mg milligram
MI myocardial infarction
ml milliliter
mm millimeter
mmol millimole




n number
Na sodium
NHANES National Health and Nutrition Examination Survey
NOAEL no-observed adverse effect level




ONTARGET ONgoing Telmisartan Alone in combination with Ramipril Global Endpoint Trial




PRA plasma renin activity
PURE Prospective Urban Rural Epidemiology


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement